Crohn’s Disease Treatment Market | Forecast 2012-23

-




SUMMARY:

Crohn's disease belongs to a condition called inflammatory bowel disease (IBD) that causes inflammation and damage to the digestive tract. Crohn's disease usually affects at the end of small intestine and beginning of colon, but inflammation may occur anywhere along the digestive tract. Crohn's disease may be hereditary or develop due to the malfunctioning of the immune system. Currently there is no cure for crohn's disease. However, there are many treatments to manage disease symptoms. Inflammation, ulcers, bowel obstruction, malnutrition, colon cancer, and anal fissures are some of the complications associated with the disease. Surgery and drug therapy are some of the treatment options available to treat Crohn's disease. Some of the anti-inflammatory drugs used to treat crohn's disease include, corticosteroids and oral 5-aminosalicylates.

The prime driver for Crohn's disease treatment market is increase in number of people being infected by the disease. In addition, increase in demand for biologics and high unmet needs within the anti-TNF refractory patient group that presents untapped market opportunities. Strong pipeline and novel mechanisms to treat Crohn's disease are fuelling the growth of Crohn's disease treatment market. However, patent expiry of the key drugs and high cost of treatment is expected to hamper the Crohn's disease treatment market globally. High R&D investment for development of biological drugs and unknown etiology of the Crohn's disease further hindering the market growth.

Global Crohn's disease treatment market is segmented based on, drug class and distribution channel

Based on drug class, Crohn's disease treatment market is segmented into
  • Antibiotics
  • Anti-Diarrheal
  • Immune System Suppressants
  • Analgesics
  • Anti-Inflammatory Drugs
  • Monoclonal Antibodies

Based on distribution channel, Crohn's disease treatment market is segmented into
  • Hospital Pharmacy
  • Retail Pharmacy
  • Others
                                                      Get Free Sample Report:

                                    Crohn’s Disease Treatment Market
Crohn's disease treatment market is expected to grow at a significant rate during the forecast period. Growth in biologics development unfolded the opportunities for the new market players as they are most commonly used in Crohn's disease treatment. Market players are focusing on to develop new products that can treat Crohn's disease. For instance, mongersen, is investigational therapy for the treatment of crohn's disease, is being developed by Celgene Corporation in phase 3 clinical trials. Considering the foreseen factors Crohn's disease treatment market is projected to have a lucrative opportunity for market players.

Geographically Crohn's disease treatment market is divided into five key regions, i.e. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America expected to contribute major share owing to increase in R&D activity and biologics approval to treat autoimmune disease. Furthermore, increase in prevalence and incidence of the Crohn's disease are expected to drive the growth of the market. According to Crohn's and Colitis Foundation of America 700,000 have crohns diseases in between 1992-2004, and 74% increase in doctor office visits due to crohn's disease. Asia-Pacific region is expected to create significant growth opportunities for the market players owing to develop infrastructure, R&D activities related to biologics and increase in prevalence of Crohn's disease in the region. Developing countries such as India and China expected to show the fastest growth owing to increase in R&D investment and healthcare expenditure in these countries

Some of the market players in Crohn's disease treatment market are Allergan, Inc. (U.S.), AbbVie Inc., (U.S.), Takeda Pharmaceutical Company Limited (Japan), Bayer AG (Switzerland), UCB S.A. (Belgium), Perrigo Company plc (Ireland), Pfizer Inc. (US), Johnson & Johnson Services, Inc. (US), and Ferring B.V. (Switzerland) to name a few

                                                          Browse Full Report:

                           Crohn’s Disease Treatment Market, 2012-2023
We have a huge database of  Healthcare-Medical search reports If you have any special requirements, please let us know and we will offer you the report as you want. 
Related Reports:

United States Crohn’s Disease Drug Market Report 2018


Contact Us:


Location: Unnamed Road, Noreikiai 38321, Lithuania

Comments

Post a Comment

Popular posts from this blog

CVX – Tigris Offshore Oil Field Development – Gulf of Mexico - Project Profile

-
Image
Synopsis "CVX – Tigris Offshore Oil Field Development – Gulf of Mexico - Project Profile" contains information on the scope of the project including project overview and location. The profile also details project ownership and funding, gives a full project description, as well as information on contracts, tendering and key project contacts. The "CVX – Tigris Offshore Oil Field Development – Gulf of Mexico - Project Profile" is part of Timetrics database of 82,000+ construction projects. Our database includes a 10+ year archive of completed projects, full coverage of all global projects with a value greater than $25 million and key contact details for project managers, owners, consultants, contractors and bidders. Summary Chevron Corporation (CVX) plans to undertake the construction of an offshore oil field platform in northwest Keathley Canyon, Gulf of Mexico, the US. The project involves the construction of a semi-submersible platform with a production ...
Read more

India Cybersecurity Market by Security, Competition & Opportunities | Forecast 2013 – 2023

-
Image
SUMMARY: According to “ India Cybersecurity Market By Security Type, By Solution, By End User Sector, Competition Forecast & Opportunities, 2013 – 2023 ”, cybersecurity market is forecast to grow at a CAGR of over 19% during 2018-2023. Growth in the market is expected to be driven by rising number of government initiatives towards digitizing government sector entities and processes, healthcare, BFSI, education and other vital sectors of the country. Rapid adoption of Social, Mobile, Analytics, Cloud & IoT (SMACT) technologies, in addition to emerging networking trends such as Software Defined Networking and Network Function Virtualization are resulting in growing complexities pertaining to data security, network infrastructure, and security regulation & compliance, thereby boosting demand for cybersecurity solutions and services across the country. Some of the major players operating in India cybersecurity market are Cisco Systems (India) Private Limited, Symantec S...
Read more

PARP Inhibitors in Oncology

-
Image
Summary: Since hitting the market in 2015, drugs that target poly (ADP-ribose) polymerase (PARP) have transformed the clinical management of cancers harboring BRCA-mutations. As more PARP inhibitors have been commercialized, drug developers are turning their attention towards broadening drug labels and exploring combination strategies. This report covers the management of PARP inhibitors in the US, Europe, and Asia, focusing on efficacy and safety comparisons for approved products, current and future indications, and research and development strategies.                                                                       Get Free Sample Report:                                               ...
Read more